Alphamab Oncology raises $60 mln

Alphamab Oncology said May 28 that it raised a $60 million Series B round led by Hudson Bay Capital Management LP. New investors including entrepreneur Adrian Cheng participated in the round, which included existing institutional investors such as China Venture Capital Fund (CVC), PAG, and Advantech Capital. Alphamab Oncology, of China, is a biopharmaceutical company developing biologics for cancer therapy.

North AmericaUSBriefs